Anúncio
Anúncio
LSTA
Lisata Therapeutics, Inc. Common Stock
1.98
USDPatrocinado
-0.08
-3.98%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.01
+0.03
+1.62%
Relatórios de Lucros LSTA
Rácio de surpresa positiva
LSTA separação 27 de 40 últimas estimativas.
68%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.52
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+6.12%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-5.45%
Lisata Therapeutics, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, LSTA reported earnings of -0.49 USD per share (EPS) for Q3 25, beating the estimate of -0.54 USD, resulting in a 10.21% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.52 USD, with revenue projected to reach -- USD, implying an aumentar of 6.12% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Lisata Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lisata Therapeutics, Inc. Common Stock reported EPS of -$0.49, beating estimates by 10.21%, and revenue of $0.00, 0% as expectations.
How did the market react to Lisata Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -12.34%, changed from $2.35 before the earnings release to $2.06 the day after.
When is Lisata Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Lisata Therapeutics, Inc. Common Stock's next earnings report?
Based on 4
analistas, Lisata Therapeutics, Inc. Common Stock is expected to report EPS of -$0.52 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio